The overall objective of this project is to develop new diagnostic
methods for earlier detection of systemic relapses and better
monitoring of operable breast cancer patients.
Our hypothesis is that liquid biopsies may enable detection of systemic relapse before they become clinically overt, and reveal relevant information in terms of prognostication and monitoring of disease progression and therapy response in operable breast cancer.